Company: PIII
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001628280-25-015305
Chunk: 319

Company: P3 Health Partners Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 8
Chunk 319
---
,675 Impairment of assets held for sale8,058 — TOTAL OPERATING EXPENSE1,821,113 1,434,305 OPERATING LOSS(320,658)(167,930)OTHER INCOME (EXPENSE):Interest expense, net(22,173)(15,985)Mark-to-market of stock warrants22,114 433 Gain on asset sale, net13,269 — Other1,457 (249)TOTAL OTHER INCOME (EXPENSE)14,667 (15,801)LOSS BEFORE INCOME TAXES(305,991)(183,731)INCOME TAX PROVISION(4,387)(2,695)NET LOSS(310,378)(186,426)LESS: NET LOSS ATTRIBUTABLE TO REDEEMABLE NON-CONTROLLING INTEREST(174,529)(128,653)NET LOSS ATTRIBUTABLE TO CONTROLLING INTEREST$(135,849)$(57,773)NET LOSS PER SHARE (Note 16):Basic$(0.94)$(0.61)Diluted$(1.08)$(0.63)WEIGHTED AVERAGE COMMON SHARES OUTSTANDING (Note 16):Basic145,175 94,889 Diluted146,998 294,590 

See accompanying notes to consolidated financial statements.

P3 Health Partners Inc. | 2024 Form 10-K | 80

P3 HEALTH PARTNERS INC. and SUBSIDIARIES 

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY AND MEZZANINE EQUITY

(in thousands)

RedeemableNon-controllingInterestClass A Common StockClass V Common StockAdditional Paid in CapitalAccumulatedDeficitTotal Stockholders’EquitySharesAmountSharesAmountSTOCKHOLDERS’ EQUITY, December 31, 2022$516,805 41,579 $4 201,592 $20 $315,375 $(309,545)$5,854 Cumulative adjustment due to adoption of new credit loss standard(124)—— —— — (26)(26)Exchanges of redeemable non-controlling interest for Class A common stock—5,3711 (5,371)(1)— —— Vesting of Class V common stock awards——— 348 1 (1)—— Issuance of Class A common stock upon settlement of restricted